Penttilä, P. A.
,
Van Gassen, S.
Panovska, D.
Vanderbeke, L.
Van Herck, Y.
Quintelier, K.
Emmaneel, A.
Filtjens, J.
Malengier-Devlies, B.
Ahmadzadeh, K.
Van Mol, P.
Borràs, D. M.
Antoranz, A.
Bosisio, F. M.
Wauters, E.
Martinod, K.
Matthys, P.
Saeys, Y.
Garg, A. D.
Wauters, J.
De Smet, F. http://orcid.org/0000-0002-6669-3335
Funding for this research was provided by:
KULeuven (C14/17/084)
KOOR - UZLeuven/KULeuven
Article History
Received: 28 October 2020
Revised: 27 January 2021
Accepted: 3 March 2021
First Online: 13 March 2021
Declaration
:
: There are no conflicts of interest to declare.
: All enrolled patients signed an informed consent to participate. The trial (S63881) was approved by the Ethical committee Research of UZLeuven/KULeuven on March 26 2020 and is registered on clinicaltrials.gov (NCT04327570)—ExternalRef removed. All patients that entered the trial gave explicit prior consent. All patients were enrolled at the ward of the hospital prior to them entering ICU.
: Not applicable. Overall, identifying details (names, dates of birth, identity numbers, biometrical characteristics (such as facial features, fingerprint, writing style, voice pattern, DNA or other distinguishing characteristic) and other information) of the participants that were studied are not published.
Free to read: This content has been made available to all.